Agilent Introduces Breakthrough Flow Cytometer
June 24 2019 - 8:00AM
Business Wire
Agilent Technologies Inc. (NYSE: A) today introduced its first
new product from recently acquired ACEA Biosciences, at the
34th Congress of the International Society for Advancement of
Cytometry, CYTO 2019 Congress, being held June 22–26, 2019
in Vancouver, Canada. The Agilent NovoCyte Advanteon Flow Cytometer
is now one of the most sensitive cell analyzers available on the
market.
Flow cytometers are integral to basic research, drug discovery,
and clinical diagnostics. The NovoCyte Advanteon accommodates
today’s high-end, and increasingly sophisticated multi-color flow
cytometry assays, providing unsurpassed sensitivity, resolution,
detection speed, and flexibility of fluorescent channels.
“Building on the success of the NovoCyte and the NovoCyte
Quanteon flow cytometers, we are excited to introduce the NovoCyte
Advanteon Flow Cytometer,” said Xiaobo Wang, Ph.D., who joined
Agilent from ACEA, as General Manager of the Flow Cytometry and
Real-Time Cell Analysis Business.
“The NovoCyte Advanteon is advancing the boundaries of benchtop
flow cytometry by providing even greater performance that customers
can trust,” added Wang.
“With the addition of the NovoCyte Advanteon to our portfolio,
Agilent has again demonstrated its commitment to providing trusted
cell analysis solutions to life science laboratories around the
world,” said Vice President and General Manager of Agilent's Cell
Analysis Division, Todd Christian. “We believe the advanced
capabilities and flexibility of the NovoCyte Advanteon technology
will provide a superior customer experience for flow cytometry
assays, and help democratize the adoption of flow cytometers across
a broad range of cell analysis applications.”
The NovoCyte Advanteon can be configured with one, two, or three
lasers and up to 21 fluorescence channels. One of the most
sensitive flow cytometers on the market today, the NovoCyte
Advanteon has a formidable 7.2 log dynamic range, combined with
fully automated compensation features. This enables users to pick
up both dim and bright signals in the same run. The resolution
metrics found on the NovoCyte Advanteon are among the best on the
market, and the system can easily discern particles in the range of
100 nanometers. Coupled with the power of a highly acclaimed and
intuitive analytical software package, the system can be fully
automated and is exceptionally easy to use.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics, and applied chemical markets. With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to
customers' most challenging questions. The company generated
revenues of $4.91 billion in fiscal 2018 and employs 15,550 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
our Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190624005170/en/
Naomi Goumillout Agilent Technologies, Inc. +1.781.266.2819
naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2024 to May 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From May 2023 to May 2024